It is the overall goal and dedication of GenPharmTox and its founders to replace, reduce and refine animal experiments whenever possible.
Accordingly, GenPharmTox offers a broad range of well established and cutting-edge innovative in vitro assays for preclinical drug development as well as safety evaluation of chemicals. By the many successful projects performed with our clients we have built an expectionally strong reputation in the area of in vitro testing.
The in vivo studies offered in co-operation with partners are planned and performed on the basis of sound science and in accordance with animal welfare legislation as well as other relevant regulatory requirements, e.g. OECD- and FDA-guidelines.